A critical discovery in cancer study is arising with the use of VHH fragments to reactivate dysfunctional p53. This vital malignant protector protein is frequently inactivated in many forms of cancer, resulting https://mnobookmarks.com/story21848756/mini-antibodies-restore-tumor-suppressor-p53-the-promising-pathway-for-cancer-treatment